19613 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 393 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
PSTPIP1Proline-serine-threonine phosphatase interacting protein 1Disease related genes
Predicted intracellular proteins
Renal cancer: 7.36e-9
Endometrial cancer: 4.74e-5
Tissue enhanced
PSTPIP2Proline-serine-threonine phosphatase interacting protein 2Predicted intracellular proteins
Nucleus
Plasma membrane
Mitochondria
Renal cancer: 2.39e-7
Tissue enhanced
PTAFRPlatelet activating factor receptorG-protein coupled receptors
Predicted membrane proteins
Transporters
Nucleoplasm
Vesicles
Plasma membrane
Tissue enhanced
PTAR1Protein prenyltransferase alpha subunit repeat containing 1Predicted intracellular proteins
Microtubule organizing center
Rods & Rings
Renal cancer: 4.65e-4
Expressed in all
PTBP1Polypyrimidine tract binding protein 1Plasma proteins
Predicted intracellular proteins
NucleoplasmLiver cancer: 2.71e-4
Expressed in all
PTBP2Polypyrimidine tract binding protein 2Plasma proteins
Predicted intracellular proteins
NucleoplasmEndometrial cancer: 7.80e-4
Mixed
PTBP3Polypyrimidine tract binding protein 3Predicted intracellular proteins
NucleusPancreatic cancer: 1.22e-4
Lung cancer: 2.10e-4
Renal cancer: 2.51e-4
Expressed in all
PTCD1Pentatricopeptide repeat domain 1Predicted intracellular proteins
MitochondriaRenal cancer: 1.13e-4
Liver cancer: 2.34e-4
Mixed
PTCD2Pentatricopeptide repeat domain 2Predicted intracellular proteins
Mixed
PTCD3Pentatricopeptide repeat domain 3Predicted intracellular proteins
Ribosomal proteins
MitochondriaStomach cancer: 6.77e-4
Urothelial cancer: 6.86e-4
Expressed in all
PTCH1Patched 1Cancer-related genes
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Golgi apparatusTissue enhanced
PTCH2Patched 2Cancer-related genes
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Pancreatic cancer: 5.74e-5
Tissue enriched
PTCHD1Patched domain containing 1Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
PTCHD3Patched domain containing 3Predicted membrane proteins
Tissue enriched
PTCHD4Patched domain containing 4Predicted membrane proteins
Plasma membrane
Cytosol
Renal cancer: 1.49e-6
Mixed
PTCRAPre T-cell antigen receptor alphaPredicted membrane proteins
Tissue enhanced
PTDSS1Phosphatidylserine synthase 1Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Nucleoplasm
Endoplasmic reticulum
Liver cancer: 1.08e-5
Lung cancer: 9.83e-4
Mixed
PTDSS2Phosphatidylserine synthase 2Enzymes
Predicted membrane proteins
Liver cancer: 5.12e-9
Expressed in all
PTENPhosphatase and tensin homologCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol
Renal cancer: 7.35e-4
Expressed in all
PTERPhosphotriesterase relatedPredicted intracellular proteins
Nucleoplasm
Cytosol
Renal cancer: 6.52e-6
Liver cancer: 2.11e-4
Expressed in all
PTF1APancreas specific transcription factor, 1aDisease related genes
Predicted intracellular proteins
Transcription factors
NucleoplasmTissue enriched
PTGDRProstaglandin D2 receptorDisease related genes
G-protein coupled receptors
Potential drug targets
Predicted membrane proteins
Tissue enhanced
PTGDR2Prostaglandin D2 receptor 2CD markers
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
PTGDSProstaglandin D2 synthaseEnzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
NucleoplasmRenal cancer: 1.19e-7
Expressed in all
PTGER1Prostaglandin E receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
PTGER2Prostaglandin E receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Renal cancer: 4.16e-4
Mixed
PTGER3Prostaglandin E receptor 3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Renal cancer: 3.50e-4
Group enriched
PTGER4Prostaglandin E receptor 4FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Urothelial cancer: 2.48e-4
Expressed in all
PTGESProstaglandin E synthaseEnzymes
Predicted membrane proteins
Endoplasmic reticulumPancreatic cancer: 7.97e-5
Colorectal cancer: 2.32e-4
Tissue enhanced
PTGES2Prostaglandin E synthase 2Enzymes
Predicted intracellular proteins
MitochondriaRenal cancer: 5.83e-7
Expressed in all
PTGES3Prostaglandin E synthase 3Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Cytosol
Liver cancer: 4.44e-6
Breast cancer: 2.15e-5
Ovarian cancer: 4.36e-4
Expressed in all
PTGES3LProstaglandin E synthase 3 likePredicted intracellular proteins
Tissue enhanced
PTGES3L-AARSD1PTGES3L-AARSD1 readthroughPredicted intracellular proteins
Nuclear membrane
Cytosol
Tissue enhanced
PTGFRProstaglandin F receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
PTGFRNProstaglandin F2 receptor inhibitorCD markers
Predicted membrane proteins
Renal cancer: 3.98e-4
Mixed
PTGIRProstaglandin I2 (prostacyclin) receptor (IP)FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 2.09e-8
Testis cancer: 1.74e-4
Tissue enhanced
PTGISProstaglandin I2 synthaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Endoplasmic reticulumRenal cancer: 4.74e-8
Urothelial cancer: 9.99e-5
Mixed
PTGR1Prostaglandin reductase 1Enzymes
Plasma proteins
Predicted intracellular proteins
Renal cancer: 5.53e-4
Expressed in all
PTGR2Prostaglandin reductase 2Enzymes
Predicted intracellular proteins
VesiclesRenal cancer: 4.55e-12
Mixed
PTGS1Prostaglandin-endoperoxide synthase 1Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Renal cancer: 8.68e-4
Urothelial cancer: 9.35e-4
Tissue enhanced
PTGS2Prostaglandin-endoperoxide synthase 2Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Endoplasmic reticulumRenal cancer: 9.79e-4
Tissue enhanced
PTHParathyroid hormoneCancer-related genes
Disease related genes
Plasma proteins
Predicted secreted proteins
Tissue enriched
PTH1RParathyroid hormone 1 receptorDisease related genes
G-protein coupled receptors
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Renal cancer: 6.79e-6
Tissue enhanced
PTH2Parathyroid hormone 2Predicted secreted proteins
Not detected
PTH2RParathyroid hormone 2 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
PTHLHParathyroid hormone like hormoneCancer-related genes
Disease related genes
Predicted secreted proteins
Nucleoplasm
Golgi apparatus
Cytosol
Renal cancer: 1.82e-9
Liver cancer: 3.37e-4
Tissue enhanced
PTK2Protein tyrosine kinase 2Cancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Vesicles
Focal adhesion sites
Cytosol
Breast cancer: 3.21e-4
Endometrial cancer: 9.11e-4
Expressed in all
PTK2BProtein tyrosine kinase 2 betaDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Plasma membrane
Cytosol
Cervical cancer: 3.32e-4
Thyroid cancer: 5.11e-4
Expressed in all
PTK6Protein tyrosine kinase 6Cancer-related genes
Enzymes
Predicted intracellular proteins
Nucleoplasm
Nuclear bodies
Plasma membrane
Cytosol
Renal cancer: 1.26e-9
Pancreatic cancer: 1.96e-4
Tissue enhanced
PTK7Protein tyrosine kinase 7 (inactive)Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Mixed
« prev | Page of 393 | next »